申请人:Sapountzis Ioannis
公开号:US20110183952A1
公开(公告)日:2011-07-28
The present invention encompasses compounds of general formula (1), wherein the groups R
1
to R
3
and L are defined as in claim
1,
which are suitable for the treatment of diseases characterised by excessive or abnormal cell proliferation, and their use for preparing a medicament having the above-mentioned properties.